Preterm birth: Case definition & guidelines for data collection, analysis, and presentation of immunisation safety data.

HOME
>
論文・技術情報
>
Preterm birth: Case definition & guidelines for data collection, analysis, and presentation of immunisation safety data.

Preterm birth: Case definition & guidelines for data collection, analysis, and presentation of immunisation safety data.

アブストラクト	Preterm birth is commonly defined as any birth before 37 weeks completed weeks of gestation. An estimated 15 million infants are born preterm globally, disproportionately affecting low and middle income countries (LMIC). It contributes directly to estimated one million neonatal deaths annually and is a significant contributor to childhood morbidity. However, in many clinical settings, the information available to calculate completed weeks of gestation varies widely. Accurate dating of the last menstrual period (LMP), as well as access to clinical and ultrasonographic evaluation are important components of gestational age assessment antenatally. This case definition assign levels of confidence to categorisation of births as preterm, utilising assessment modalities which may be available across different settings. These are designed to enable systematic safety evaluation of vaccine clinical trials and post-implementation programmes of immunisations in pregnancy.
ジャーナル名	Vaccine
Pubmed追加日	2016/10/17
投稿者	Quinn, Julie-Anne; Munoz, Flor M; Gonik, Bernard; Frau, Lourdes; Cutland, Clare; Mallett-Moore, Tamala; Kissou, Aimee; Wittke, Frederick; Das, Manoj; Nunes, Tony; Pye, Savia; Watson, Wendy; Ramos, Ana-Maria Alguacil; Cordero, Jose F; Huang, Wan-Ting; Kochhar, Sonali; Buttery, Jim
組織名	SAEFVIC, Murdoch Childrens Research Institute, Victoria, Australia; Infection and;Immunity, Monash Children's Hospital, Department of Paediatrics, The Ritchie;Centre, Hudson Institute, Monash University, Australia.;Departments of Pediatrics and Molecular Virology and Microbiology, Baylor College;of Medicine, Houston, TX, USA.;Department of Obstetrics and Gynecology, Wayne State University, Detroit, MI,;USA.;LMF Pharmacoepidemiology, New York, USA.;Medical Research Council: Respiratory and Meningeal Pathogens Research Unit,;Department of Science and Technology National Research Foundation, Vaccine;Preventable Diseases, Faculty of Health Sciences, University of the;Witwatersrand, Johannesburg, South Africa.;Global Pharmacovigilance, Sanofi Pasteur, Swiftwater, Philadelphia, USA.;Department of Pediatrics, Souro Sanou Teaching Hospital, Bobo-Dioulasso, Burkina;Faso.;Debiopharm International SA, Lausanne, Switzerland.;INCLEN Trust International, India.;Optum Epidemiology, Providence, RI, USA.;Communicable Disease Prevention and Control, Nova Scotia, Canada.;Pfizer Inc, Collegeville, PA, USA.;Direccion General de Salud Publica, Avd Cataluna n degrees 21, 46020 Valencia,;Spain.;University of Puerto Rico Graduate School of Public Health, Medical Sciences;Campus, San Juan 00935, Puerto Rico.;Taiwan Centers for Disease Control, Taipei, Taiwan.;Global Healthcare Consulting, India.;Centre, Hudson Institute, Monash University, Australia. Electronic address:;contact@brightoncollaboration.org.
Pubmed リンク	https://www.ncbi.nlm.nih.gov/pubmed/27743648/